Search

everythinglearnresearchcommunity

for

Search:↓

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Potential new drugs for treating PCOS were identified.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Hirsutism causes significant psychological distress in women.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Vitamin D is essential for bone health and may reduce risks of several diseases.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.